BioSpace News Archive

Drug Development

Lysogene Becomes Latest Company to Fail with AAVs in CNS Disorders (Updated)

Lysogene’s investigational gene therapy LYS-SAF302 failed to meet its primary and key secondary efficacy endpoints in mucopolysaccharidosis type IIIA.

November 21, 2022
·
3 min read
·
Tristan Manalac
Policy

FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs

The FDA has a number of PDUFA dates for the remainder of November for Spectrum, ImmunoGen, Scynexis and Y-mAbs.

November 21, 2022
·
2 min read
·
Mark Terry
Drug Development

Gratitude and Optimism: This Thanksgiving, BioSpace Celebrates Biopharma Wins

In a volatile year, marked with challenges, BioSpace is taking a pause to reflect on the many “wins” in biopharma.

November 21, 2022
·
4 min read
·
Lisa Munger
Drug Development

Merck Acquires Imago and its LSD1 Inhibitors in $1.3B Deal (Updated)

With a $1.36 billion buyout, Merck bolstered its oncology program with the acquisition of Biotech Bay-based Imago Biosciences, a company focused on chronic bone marrow cancers.

November 21, 2022
·
3 min read
·
Alex Keown
Business

Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO

Teva Pharmaceuticals has found its new president and CEO. Effective Jan. 1, 2023, Richard Francis will take the company’s reins as Kåre Schultz retires.

November 21, 2022
·
2 min read
·
Mark Terry
Vaccitech to Host KOL Webinar on the SNAPvax™ Platform for Inducing Tolerance to Treat Celiac and other Autoimmune Diseases

Vaccitech plc (NASDAQ: VACC) today announced that it will host a Key Opinion Leader (KOL) webinar on its SNAPvax™ Platform and application in tolerogenic immunotherapies for celiac disease and other autoimmune diseases on Monday, November 28, 2022 at 4:30 pm ET.

November 21, 2022
·
5 min read
Biotech Beach

Cardiff Oncology to Present at Upcoming Investor Conferences

Cardiff Oncology, Inc. today announced that company management will participate in fireside chats and 1x1 investor meetings at the 34th Annual Piper Sandler Healthcare Conference.

November 21, 2022
·
1 min read
Kymanox Named as Winner of 2022 Triangle Business Journal Fast 50 Award

Triangle Business Journal held awards ceremony on Wednesday, 09 November 2022

November 21, 2022
·
2 min read
Diagnostic Imaging Services Market Revenue to Surpass USD 545.7 BN by 2030

According to Nova one advisor, the global Diagnostic Imaging Services market size is expected to hit around USD 545.7 billion by 2030 from valued at USD 364.2 billion in 2022 and growing at a CAGR of 5.10% from 2022 to 2030.

November 21, 2022
·
9 min read
Deals

Millstone Medical Outsourcing, an Arlington Capital Partners Portfolio Company, Acquires MycoScience

Millstone Medical Outsourcing (“Millstone”), the industry’s leading partner of choice for medical manufacturers’ post-manufacturing and aftermarket services, announces its completed acquisition of MycoScience, on November 14, 2022.

November 21, 2022
·
4 min read